Julia E. Prescott
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Epigenetics and DNA Methylation
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
- Cancer-related gene regulation
- Mitochondrial Function and Pathology
- Genomics and Chromatin Dynamics
Papers in
-
- Ubiquitin and proteasome pathways 3
- Cancer-related gene regulation 2
- Wnt/β-catenin signaling in development and cancer 1
- Oncology 4
- Cancer-related Molecular Pathways 4
- Co-authors
- Chi V. Dang (5 shared papers)E Emison (1 shared paper)Karen Zeller (1 shared paper)Qing Li (1 shared paper)Diane R. Wonsey (1 shared paper)Linda Resar (1 shared paper)Sunkyu Kim (1 shared paper)Brian C. Lewis (2 shared papers)
- Journals
- Molecular Cancer Therapeutics (1 paper)Cancer Research (1 paper)BMC Genomics (1 paper)Journal of Biological Chemistry (1 paper)Experimental Cell Research (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Julia E. Prescott
9 papers receiving 644 citations
Peers
Comparison fields: 5 of 74
- Cancer Research 149
- Molecular Biology 521
- Oncology 191
- Cell Biology 48
- Immunology 56
Countries citing papers authored by Julia E. Prescott
This map shows the geographic impact of Julia E. Prescott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia E. Prescott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia E. Prescott more than expected).
Fields of papers citing papers by Julia E. Prescott
This network shows the impact of papers produced by Julia E. Prescott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia E. Prescott. The network helps show where Julia E. Prescott may publish in the future.
Co-authors
The 25 scholars most cited alongside Julia E. Prescott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 316 | |
| 2 | Tumor induction by the c-Myc target genes rcl and lactate dehydrogenase A. | 2000 | 85 |
| 3 | 1996 | 56 | |
| 4 | 2001 | 55 | |
| 5 | 2005 | 53 | |
| 6 | 2008 | 41 | |
| 7 | 2006 | 33 | |
| 8 | 2005 | 14 | |
| 9 | PCI-27483, a small molecule inhibitor of factor VIIa, inhibits tumor growth in vivo. | 2007 | 1 |
About Julia E. Prescott
Julia E. Prescott is a scholar working on Molecular Biology, Oncology, Hematology, Cancer Research and Pathology and Forensic Medicine, having authored 9 papers that have together received 654 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (4 papers), Ubiquitin and proteasome pathways (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Cancer-related gene regulation (2 papers), Hemophilia Treatment and Research (1 paper), Cancer Research and Treatments (1 paper), Wnt/β-catenin signaling in development and cancer (1 paper) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Cancer Research (149 citations), Molecular Biology (521 citations), Oncology (191 citations), Cell Biology (48 citations) and Immunology (56 citations). Julia E. Prescott has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Chi V. Dang, E Emison, Karen Zeller, Qing Li, Diane R. Wonsey, Linda Resar, Sunkyu Kim, Brian C. Lewis, S. Elizabeth Campbell and Kenneth J. Cohen. Their work appears in journals such as Molecular Cancer Therapeutics, Cancer Research, BMC Genomics, Journal of Biological Chemistry and Experimental Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.